Dyskinesia of esophagus

disease
On this page

Also known as esophageal motility disorderoesophageal dysmotilityoesophageal motor disorder

Summary

Dyskinesia of esophagus (MONDO:0004729) is a disease and 26 clinical trials. Top therapeutic interventions include prucalopride, codeine phosphate, and famotidine. A subtype of esophageal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 26

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namedyskinesia of esophagus
Mondo IDMONDO:0004729
MeSHD015154
DOIDDOID:9192
ICD-10-CMK22.4
ICD-11581725607
SNOMED CT266434009
UMLSC0014858
MedGen41868
Is cancer (heuristic)no

Also known as: dyskinesia of esophagus · esophageal motility disorder · oesophageal dysmotility · oesophageal motor disorder

Disease family

This is a subtype of esophageal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderupper digestive tract disorderesophageal disorderdyskinesia of esophagus

Related subtypes (19): esophageal atresia, esophageal varices, esophagitis, megaesophagus, esophageal tuberculosis, esophageal leukoplakia, esophageal diverticulosis, gastroesophageal reflux disease, esophageal atresia/tracheoesophageal fistula, achalasia, Barrett esophagus, esophageal duplication cyst, tubular duplication of the esophagus, laryngotracheoesophageal cleft, isolated tracheo-esophageal fistula, congenital esophageal diverticulum, neoplasm of esophagus, esophageal ulcer, congenital esophageal stenosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 26.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified20
PHASE43
PHASE23

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05455359PHASE4RECRUITINGGastrointestinal Dysmotility on Aspiration Risk
NCT02736734PHASE4COMPLETEDThe Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers
NCT03784105PHASE4COMPLETEDCodeine on Pharyngeal and Esophageal Motility
NCT01302301PHASE2UNKNOWNEndolumenal Partial Myotomy for Esophageal Motility Disorders
NCT01448993PHASE2COMPLETEDEffect of Azithromycin on Oesophageal Hypomotility
NCT05604261PHASE2UNKNOWNA Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
NCT05132816Not specifiedRECRUITINGHigh Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux
NCT05272046Not specifiedACTIVE_NOT_RECRUITINGMonopolar and Bipolar Current RFA Knife in POEM
NCT05380791Not specifiedRECRUITINGEffect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After ARS in Patients With GERD
NCT06878586Not specifiedNOT_YET_RECRUITINGDiagnostic Evaluation of Esophageal Motility Disorders Using the Chicago IV Protocol in Egypt
NCT07496840Not specifiedRECRUITINGClinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)
NCT01234428Not specifiedCOMPLETEDEsophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding
NCT01447823Not specifiedUNKNOWNObservational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring
NCT01658865Not specifiedUNKNOWNAssessment of Esophageal Motility With Transnasal Endoscopy
NCT02663206Not specifiedWITHDRAWNPeroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
NCT03012854Not specifiedUNKNOWNDifferent Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia
NCT03100357Not specifiedUNKNOWNChanges in Esophageal Motility and Swallowing Symptoms After Thyroid Surgery
NCT03347903Not specifiedCOMPLETEDPrevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease
NCT03662490Not specifiedUNKNOWNCorrelation Between Clinical Signs and High-resolution Manometry Data in Children
NCT03904004Not specifiedUNKNOWNPressure and Flow Study Before and After Treatments for EMD. The pFlow Study
NCT05402462Not specifiedUNKNOWNEsophageal Motility Disorders in Patients With Non-cardiac Chest Pain at Assiut University Hospital
NCT05913011Not specifiedUNKNOWNPrevalence of IEM Among Upper GIT Symptoms
NCT06314893Not specifiedTERMINATEDEstablishing a Correlation Between HRM and UGI MM Studies
NCT06329583Not specifiedCOMPLETEDEstablishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
NCT06629025Not specifiedCOMPLETEDThe Clinical Manifestation and Prognosis of Pediatric Esophageal Motility Disorders
NCT06918730Not specifiedCOMPLETEDU-POEM vs CO2-POEM

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
PRUCALOPRIDE42
CODEINE PHOSPHATE41
FAMOTIDINE41
RABEPRAZOLE41
ANAPRAZOLE31
CHEMBL474702801